Palliative esophageal stent or surgery in advanced esophageal malignancy.

Simple item page
dc.contributor.authorManomaipiboon, Aen_US
dc.contributor.authorWattanasirichaigoon, Sen_US
dc.contributor.authorSrisaovajate, Sen_US
dc.contributor.authorThanapongsathorn, Wen_US
dc.contributor.authorNggitphaiboon, Wen_US
dc.contributor.authorSangpayup, Yen_US
dc.date.accessioned2009-05-27T17:59:08Z
dc.date.available2009-05-27T17:59:08Z
dc.date.issued2001-10-24en_US
dc.descriptionChotmaihet Thangphaet.en_US
dc.description.abstractEsophageal malignancy is one of the most aggressive malignancies. Unfortunately, the majority of patients present with incurable disease. Then palliative treatment to relieve dysphagia is the mainstay of treatment. We compared the mortality, procedure-related complications, hospital stay, intervention time, improvement of dysphagia and survival time between esophageal stent and surgery. There were twenty patients who underwent esophageal stent and twenty-three patients underwent surgical treatment. Pretreatment characteristics were similar between the two groups. The mortality between the surgical group and the esophageal stent group was 30.43 per cent (7/23) and 5 per cent (1/20) (p<0.05). The complications in the surgical group included anastomotic leakage 39.13 per cent (9/23), wound dehiscence 4.35 per cent (1/23), small bowel obstruction 4.35 per cent (1/23) and late anastomotic stricture 37.5 per cent (6/16). In the esophageal stent group, the complications were severe chest pain 10 per cent (2/20), stent displacement 10.52 per cent (2/19), stent obstruction from food impaction 15.78 per cent (3/19) and tumor overgrowth leading to stent obstruction 5.26 per cent (1/19). More intervention time and hospital stay (post intervention period and ICU period) was spent in the surgical group (320.43+/-133.84 mins vs 57.5+/-23.98 mins p<0.001, 30.39+/-20.69 days vs 4.9+/-2.61 days p<0.001, 9.79+/-16.64 days vs 0 days p<0.05). The improvement of dysphagia was 1.00+/-1.03 vs 1.75+/-0.72 (p<0.05). Survival between the two groups was not statistically different (p>0.05).en_US
dc.description.affiliationDepartment of Surgery, Bangkok Metropolitan Administration Medical College and Vajira Hospital, Thailand.en_US
dc.identifier.citationManomaipiboon A, Wattanasirichaigoon S, Srisaovajate S, Thanapongsathorn W, Nggitphaiboon W, Sangpayup Y. Palliative esophageal stent or surgery in advanced esophageal malignancy. Journal of the Medical Association of Thailand. 2001 Oct; 84(10): 1443-8en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/38215
dc.language.isoengen_US
dc.source.urihttps://www.mat.or.th/journal/all.phpen_US
dc.subject.meshChi-Square Distributionen_US
dc.subject.meshEsophageal Neoplasms --mortalityen_US
dc.subject.meshHumansen_US
dc.subject.meshLength of Stay --statistics & numerical dataen_US
dc.subject.meshPalliative Careen_US
dc.subject.meshPostoperative Complications --epidemiologyen_US
dc.subject.meshStatistics, Nonparametricen_US
dc.subject.meshStentsen_US
dc.subject.meshSurvival Analysisen_US
dc.subject.meshThailand --epidemiologyen_US
dc.subject.meshTreatment Outcomeen_US
dc.titlePalliative esophageal stent or surgery in advanced esophageal malignancy.en_US
dc.typeComparative Studyen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Medical Association of Thailand